GlassScriptPhysician profile
Jason Travis Stack
NPI 1164869699
$15,470.03
in general payments reported to CMS, 2019-2025
21 companies · $944 in 2025
The $944 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,396 · 2020: $544 · 2021: $3,133 · 2022: $2,226 · 2023: $3,192 · 2024: $2,035 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,789 · Travel and Lodging: $958 · Consulting Fee: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,789.04 |
| Travel and Lodging | $958.05 |
| Consulting Fee | $423.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $10,496.78 | 2019-2025 | Mako, Triathlon, Insignia |
| Corin USA | $1,479.37 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,347.97 | 2019-2025 | Affixus |
| Smith+Nephew, INC. | $526.29 | 2019-2025 | Pico 14, Redapt, "Acticoat 4"" X 4""" |
| Depuy Synthes Sales INC. | $430.07 | 2019-2024 | Na |
| Hikma Pharmaceuticals USA | $423.20 | 2024 | Combogesic IV |
| Pacira Pharmaceuticals Incorporated | $226.95 | 2021-2025 | Iovera, Exparel, Zilretta |
| Medical Device Business Services, INC. | $92.32 | 2019 | |
| Pacira Therapeutics, INC. | $88.47 | 2019-2021 | |
| Amgen INC. | $87.61 | 2019-2023 | Prolia, Evenity |
| Bioventus LLC | $73.78 | 2019-2022 | |
| Carbofix Orthopedics INC | $49.20 | 2019 | |
| Radius Health, INC. | $25.57 | 2019-2020 | |
| Vericel Corporation | $24.56 | 2022 | |
| Fidia Pharma USA INC. | $24.29 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $16.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.06 | 2022 | |
| Kci USA, INC. | $13.38 | 2023 | Prevena |
| Checkpoint Surgical, INC | $11.52 | 2020 | |
| Theragen, INC. | $11.02 | 2020 | |
| Heraeus Medical, LLC. | $7.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Stack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.